Market Overview:
The global furosemide injection market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of chronic diseases, rising geriatric population, and growing demand for better healthcare facilities. By type, the 20mg/2ml segment is expected to account for the largest share of the global furosemide injection market in 2018. This segment is also projected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030.
Product Definition:
Furosemide injection is a diuretic used to help the body get rid of excess water. It is used to treat high blood pressure, heart failure, and other conditions.
20mg/2ml:
20mg/2ml is a concentration used for the treatment of heart failure and pulmonary edema. It works by opening up the blood vessels to allow more blood flow which ultimately increases the oxygen level in the body. The 20 mg/2 ml solution is given intravenously, it's effect lasts for about 45 minutes and then it has to be injected again.
The growth factor in 20mg/2ml is Furosemide, it's main function is to widen.
40mg/40ml:
40mg/40ml is a concentration of Furosemide used for injection. It is also known as hydroxypropyl methyl cellulose and Esterified Propoxy late Glycerol (EPG). It has a molecular weight of about 394.2 and an ionic strength of about 1.5, which makes it an ideal binder for intravenous solutions and injectable formulations in the pharmaceutical industry.
Application Insights:
The hospital application segment accounted for the largest revenue share in 2016 and is projected to continue its dominance over the forecast period. Rising cases of heart-related problems, especially cardiac arrest among old people will boost demand for furosemide injection in hospitals. Moreover, increasing awareness about these injections among patients visiting hospitals will fuel demand further.
The clinics application segment is expected to register a significant CAGR of XX% from 2017 to 2030 owing to an increase in the number of outpatient visits due primarily to lifestyle disorders such as obesity and high blood pressure levels that result in increased risk factors for cardiovascular diseases.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position throughout the forecast period owing to increasing number of hospitals, recovery centers and clinics that provide healthcare services for patients suffering from pulmonary edema. Moreover, growing awareness regarding disorders related to heart and blood vessels among people in North America is also one of the major factors responsible for market growth in this region.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising incidence of heart diseases & hypertension coupled with an aging population that requires long-term therapy for management of fluid balance. In addition, improving healthcare facilities & infrastructure along with rising patient awareness about treatment options are some other factors likely contribute toward regional demand over the next eight years.
Growth Factors:
- Increasing prevalence of heart failure: The global prevalence of heart failure is expected to increase from 26 million in 2011 to over 40 million by 2030. This will create a large pool of patients who will require treatment, including Furosemide Injection.
- Growing awareness about the benefits of early diagnosis and treatment: There is growing awareness among both physicians and patients about the benefits of early diagnosis and treatment for heart failure. This is likely to lead to increased use of Furosemide Injection in the coming years.
- Technological advances in cardiac care: Advances in technology are helping improve the diagnosis and treatment options for heart failure patients, including those treated with Furosemide Injection. This is likely to result in increased adoption rates for this drug over time.
Scope Of The Report
Report Attributes
Report Details
Report Title
Furosemide Injection Market Research Report
By Type
20mg/2ml, 40mg/40ml, 100mg/10ml
By Application
Hospital, Clinics, Recovery Center
By Companies
AuroMedics, Baxter, Fresenius Kabi, Pfizer, Avet Pharmaceuticals, SteriMax, Hunan Kelun Pharmaceutical, Hainan Huanglong Pharm, Shenyang Guagnda Pharm, Shagnhai Harvest Pharamceutical, Chengdu Brilliant Pharmaceutical, Changbaishan Pharmaceutical, CSPC Ouyi Pharm
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
234
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Furosemide Injection Market Report Segments:
The global Furosemide Injection market is segmented on the basis of:
Types
20mg/2ml, 40mg/40ml, 100mg/10ml
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinics, Recovery Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AuroMedics
- Baxter
- Fresenius Kabi
- Pfizer
- Avet Pharmaceuticals
- SteriMax
- Hunan Kelun Pharmaceutical
- Hainan Huanglong Pharm
- Shenyang Guagnda Pharm
- Shagnhai Harvest Pharamceutical
- Chengdu Brilliant Pharmaceutical
- Changbaishan Pharmaceutical
- CSPC Ouyi Pharm
Highlights of The Furosemide Injection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 20mg/2ml
- 40mg/40ml
- 100mg/10ml
- By Application:
- Hospital
- Clinics
- Recovery Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Furosemide Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Furosemide injection is a medication used to lower blood pressure. It works by relaxing blood vessels and reducing the amount of fluid that circulates in the body.
Some of the key players operating in the furosemide injection market are AuroMedics, Baxter, Fresenius Kabi, Pfizer, Avet Pharmaceuticals, SteriMax, Hunan Kelun Pharmaceutical, Hainan Huanglong Pharm, Shenyang Guagnda Pharm, Shagnhai Harvest Pharamceutical, Chengdu Brilliant Pharmaceutical, Changbaishan Pharmaceutical, CSPC Ouyi Pharm.
The furosemide injection market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Furosemide Injection Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Furosemide Injection Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Furosemide Injection Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Furosemide Injection Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Furosemide Injection Market Size & Forecast, 2020-2028 4.5.1 Furosemide Injection Market Size and Y-o-Y Growth 4.5.2 Furosemide Injection Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 20mg/2ml
5.2.2 40mg/40ml
5.2.3 100mg/10ml
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinics
6.2.3 Recovery Center
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Furosemide Injection Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Furosemide Injection Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 20mg/2ml
9.6.2 40mg/40ml
9.6.3 100mg/10ml
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinics
9.10.3 Recovery Center
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 20mg/2ml
10.6.2 40mg/40ml
10.6.3 100mg/10ml
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinics
10.10.3 Recovery Center
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 20mg/2ml
11.6.2 40mg/40ml
11.6.3 100mg/10ml
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinics
11.10.3 Recovery Center
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 20mg/2ml
12.6.2 40mg/40ml
12.6.3 100mg/10ml
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinics
12.10.3 Recovery Center
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 20mg/2ml
13.6.2 40mg/40ml
13.6.3 100mg/10ml
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinics
13.10.3 Recovery Center
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Furosemide Injection Market: Competitive Dashboard
14.2 Global Furosemide Injection Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AuroMedics
14.3.2 Baxter
14.3.3 Fresenius Kabi
14.3.4 Pfizer
14.3.5 Avet Pharmaceuticals
14.3.6 SteriMax
14.3.7 Hunan Kelun Pharmaceutical
14.3.8 Hainan Huanglong Pharm
14.3.9 Shenyang Guagnda Pharm
14.3.10 Shagnhai Harvest Pharamceutical
14.3.11 Chengdu Brilliant Pharmaceutical
14.3.12 Changbaishan Pharmaceutical
14.3.13 CSPC Ouyi Pharm